Pfizer Announces Coronavirus Vaccine Data Shows 90% Success Rate

Pfizer Announces Coronavirus Vaccine Data Shows 90% Success Rate

In the midst of a surge in coronavirus cases, Pfizer announced that the COVID-19 vaccine it has been working on appears to be 90% effective.

Pharmaceutical company Pfizer Inc. revealed on November 9 that the COVID-19 vaccine it is developing may be 90% effective, according to the Associated Press.

This estimation is based on incomplete test results of a study of 44,000 people, where 94 of them were infected. Some participants in the study were given the vaccine and others were given a placebo—it is assumed that most of the infections occurred in those who received the placebo.

“We’re in a position potentially to be able to offer some hope,” said Dr. Bill Gruber, Pfizer’s senior vice president of clinical development.

Pfizer is developing the vaccine in partnership with the German company BioNTech. Pfizer will be applying for emergency-use approval from the FDA later this month.

About the Author

Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.

Download Center

  • EHS Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - September 2021

    September 2021

    Featuring:

    • COMBUSTIBLE DUST
      Managing Combustible Dust and Risk Mitigation
    • PPE: CONSTRUCTION
      The Rising Popularity of Safety Helmets on the Jobsite
    • PPE: ELECTRICAL SAFETY
      Five Tips for a Successful Wear Trial
    • SAFETY & HEALTH
      Medical Surveillance Versus Medical Screening
    View This Issue